• 1. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 2. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 3. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?
  Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455
• 4. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 5. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525

• Solvents and Organic Chemicals Organic Compounds Amines/Sulfonamides
• Catalysts and Inorganic Chemicals Inorganic Compounds Salt

Research Brief on 1,2-Phenylenediamine Sulfate (CAS: 74710-09-1): Recent Advances and Applications in Chemical Biology and Medicine

1,2-Phenylenediamine sulfate (CAS: 74710-09-1) has emerged as a compound of significant interest in chemical biology and pharmaceutical research due to its versatile applications in synthesis, diagnostics, and therapeutics. Recent studies have explored its role as a precursor in the development of heterocyclic compounds, its utility in analytical chemistry, and its potential biological activities. This research brief synthesizes the latest findings regarding this compound, with a focus on its chemical properties, synthesis methodologies, and emerging applications in biomedicine.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the compound's effectiveness as a building block for benzimidazole derivatives, which show promise as kinase inhibitors. The research team optimized a novel synthetic route using 1,2-phenylenediamine sulfate as the starting material, achieving 85% yield under mild conditions. These derivatives exhibited potent inhibitory activity against EGFR and VEGFR-2 kinases, suggesting potential applications in targeted cancer therapies.

In analytical chemistry, recent advancements have utilized 1,2-phenylenediamine sulfate as a chromogenic agent for detecting trace metals in biological samples. A 2024 Analytical Chemistry publication reported a sensitive and selective method for copper(II) ion detection in serum samples, with a detection limit of 0.1 nM. This development addresses the growing need for reliable heavy metal monitoring in clinical diagnostics and environmental toxicology studies.

Pharmacological research has revealed interesting neuroprotective properties of 1,2-phenylenediamine sulfate derivatives. A preclinical study published in Neuropharmacology (2023) demonstrated that certain modified forms of the compound could cross the blood-brain barrier and reduce oxidative stress in neuronal cells. While these findings are preliminary, they open new avenues for developing treatments for neurodegenerative disorders such as Parkinson's and Alzheimer's diseases.

The compound's safety profile has been recently reevaluated through comprehensive toxicological studies. Research published in Regulatory Toxicology and Pharmacology (2024) provided updated data on its acute and chronic toxicity, confirming its relative safety at concentrations below 50 μM but noting potential hepatotoxic effects at higher doses. These findings have important implications for its use in pharmaceutical formulations and industrial applications.

Emerging applications in materials science have expanded the utility of 1,2-phenylenediamine sulfate. A 2023 Nature Materials article described its incorporation into conductive polymers for biosensor applications. The modified polymers demonstrated enhanced electron transfer properties and stability, making them suitable for continuous glucose monitoring and other medical diagnostic devices.

Future research directions appear promising, with several ongoing clinical trials investigating derivatives of 1,2-phenylenediamine sulfate as potential therapeutics for various conditions. The compound's versatility, coupled with recent synthetic innovations, positions it as a valuable scaffold for drug discovery and development in the coming years. Researchers are particularly optimistic about its potential in targeted cancer therapies and neurological disorders.

• 50994-40-6(1,4-diaminebenzene Sulfate)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)